|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang J and Zhang W: New molecular insights
into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martin M, Geudens I, Bruyr J, Potente M,
Bleuart A, Lebrun M, Simonis N, Deroanne C, Twizere JC, Soubeyran
P, et al: PP2A regulatory subunit Bα controls endothelial
contractility and vessel lumen integrity via regulation of HDAC7.
EMBO J. 32:2491–2503. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kakimoto Y, Ito S, Abiru H, Kotani H,
Ozeki M, Tamaki K and Tsuruyama T: Sorbin and SH3 domain-containing
protein 2 is released from infarcted heart in the very early phase:
Proteomic analysis of cardiac tissues from patients. J Am Heart
Assoc. 2:e0005652013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bielack SS, Hecker-Nolting S, Blattmann C
and Kager L: Advances in the management of osteosarcoma. F1000Res.
5:27672016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhen N, Yang Q, Zheng K, Han Z, Sun F, Mei
W and Yu Y: MiroRNA-127-3p targets XRCC3 to enhance the
chemosensitivity of esophageal cancer cells to a novel
phenanthroline-dione derivative. Int J Biochem Cell Biol.
79:158–167. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Inui M, Martello G and Piccolo S: MicroRNA
control of signal transduction. Nat Rev Mol Cell Biol. 11:252–263.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sharma T, Hamilton R and Mandal CC:
miR-214: A potential biomarker and therapeutic for different
cancers. Future Oncol. 11:349–363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Penna E, Orso F and Taverna D: miR-214 as
a key hub that controls cancer networks: Small player, multiple
functions. J Invest Dermatol. 135:960–969. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Allen-Rhoades W, Kurenbekova L,
Satterfield L, Parikh N, Fuja D, Shuck RL, Rainusso N, Trucco M,
Barkauskas DA, Jo E, et al: Cross-species identification of a
plasma microRNA signature for detection, therapeutic monitoring,
and prognosis in osteosarcoma. Cancer Med. 4:977–988. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Z and Cai H, Lin L, Tang M and Cai H:
Upregulated expression of microRNA-214 is linked to tumor
progression and adverse prognosis in pediatric osteosarcoma.
Pediatr Blood Cancer. 61:206–210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu Y, He J, Wang Y, Zhu X, Pan Q, Xie Q
and Sun F: miR-889 promotes proliferation of esophageal squamous
cell carcinomas through DAB2IP. FEBS Lett. 589:1127–1135. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liesenfeld M, Mosig S, Funke H, Jansen L,
Runnebaum IB, Dürst M and Backsch C: SORBS2 and TLR3 induce
premature senescence in primary human fibroblasts and
keratinocytes. BMC Cancer. 13:5072013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao X, Lu C, Chu W, Zhang Y, Zhang B,
Zeng Q, Wang R, Li Z, Lv B and Liu J: microRNA-214 governs lung
cancer growth and metastasis by targeting carboxypeptidase-D. DNA
Cell Biol. 35:715–721. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Srivastava A, Goldberger H, Dimtchev A,
Ramalinga M, Chijioke J, Marian C, Oermann EK, Uhm S, Kim JS, Chen
LN, et al: MicroRNA profiling in prostate cancer-the diagnostic
potential of urinary miR-205 and miR-214. PLoS One. 8:e769942013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cristobal I, Caramés C, Madoz-Gurpide J,
Rojo F, Aguilera O and Garcia-Foncillas J: Downregulation of
miR-214 is specific of liver metastasis in colorectal cancer and
could play a role determining the metastatic niche. Int J
Colorectal Dis. 29:8852014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu Q, Xu L, Li C, Yuan Y, Huang S and Chen
H: miR-214 inhibits invasion and migration via downregulating
GALNT7 in esophageal squamous cell cancer. Tumour Biol.
37:14605–14614. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Teicher BA: Searching for molecular
targets in sarcoma. Biochem Pharmacol. 84:1–10. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poos K, Smida J, Nathrath M, Maugg D,
Baumhoer D and Korsching E: How microRNA and transcription factor
co-regulatory networks affect osteosarcoma cell proliferation. PLoS
Comput Biol. 9:e10032102013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu Z and Wang T: miR-214 promotes the
proliferation and invasion of osteosarcoma cells through direct
suppression of LZTS1. Biochem Biophys Res Commun. 449:190–195.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Inoue T, Hagiyama M, Enoki E, Sakurai MA,
Tan A, Wakayama T, Iseki S, Murakami Y, Fukuda K, Hamanishi C and
Ito A: Cell adhesion molecule 1 is a new osteoblastic cell adhesion
molecule and a diagnostic marker for osteosarcoma. Life Sci.
92:91–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
You Y, Zhang J, Li Y, Li Y, Shi G, Ma L
and Wei H: CADM1/TSLC1 inhibits melanoma cell line A375 invasion
through the suppression of matrix metalloproteinases. Mol Med Rep.
10:2621–2626. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang W, Xie HY, Ding SM, Xing CY, Chen A,
Lai MC, Zhou L and Zheng SS: CADM1 regulates the G1/S transition
and represses tumorigenicity through the Rb-E2F pathway in
hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int.
15:289–296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Z, Wang R, Zhang T and Dong X:
MicroRNA-126 regulates migration and invasion of gastric cancer by
targeting CADM1. Int J Clin Exp Pathol. 8:8869–8880.
2015.PubMed/NCBI
|
|
26
|
Vallath S, Sage EK, Kolluri KK, Lourenco
SN, Teixeira VS, Chimalapati S, George PJ, Janes SM and Giangreco
A: CADM1 inhibits squamous cell carcinoma progression by reducing
STAT3 activity. Sci Rep. 6:240062016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Katoh M: Cardio-miRNAs and onco-miRNAs:
Circulating miRNA-based diagnostics for non-cancerous and cancerous
diseases. Front Cell Dev Biol. 2:612014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Murakami S, Sakurai-Yageta M, Maruyama T
and Murakami Y: Trans-homophilic interaction of CADM1 activates
PI3K by forming a complex with MAGuK-family proteins MPP3 and Dlg.
PLoS One. 9:e1100622014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cao Q, Mao ZD, Shi YJ, Chen Y, Sun Y,
Zhang Q, Song L and Peng LP: MicroRNA-7 inhibits cell
proliferation, migration and invasion in human non-small cell lung
cancer cells by targeting FAK through ERK/MAPK signaling pathway.
Oncotarget. 7:77468–77481. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Wang J, Lv Z, Zhao D and Luo M:
Cox-2 promotes mesenchymal stem cells differentiation into
cardiocytes by activating JNK and ERK pathway. Biochem Biophys Res
Commun. 480:101–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
